Biondo Investment Advisors’s Pacific Biosciences PACB Stock Holding History

Biondo Investment Advisors’s Portfolio PACB Stock Details PACB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q2	–	Sell	-19,500	Closed	-$137K	–	86
2017 Q1	$137K	Buy	+19,500	New	+$95.4K	0.05%	75
2016 Q4	–	Sell	-19,500	Closed	-$175K	–	77
2016 Q3	$175K	Hold	19,500	–	–	0.06%	76
2016 Q2	$137K	Hold	19,500	–	–	0.05%	75
2016 Q1	$166K	Hold	19,500	–	–	0.06%	72
2015 Q4	$256K	Buy	+19,500	New	+$175K	0.08%	74

Other funds holding PACB

Maverick Capital Dallas, Texas $11.3B AUM 76.6% 1-Year Est. Return

OIM

Oracle Investment Management Greenwich, Connecticut $168M AUM 42.86% 1-Year Est. Return

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

RCM

Raging Capital Management Rocky Hill, New Jersey $18.2M AUM 17.75% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

CCM

Consonance Capital Management New York $7.28M AUM 43.59% 1-Year Est. Return

ACH

ArrowMark Colorado Holdings Denver, Colorado $2.4B AUM 42.85% 1-Year Est. Return

Blackstone Inc New York $39B AUM 18.55% 1-Year Est. Return

Biondo Investment Advisors's PACB Position: Q2 2017 in Review

Biondo Investment Advisors sold out of Pacific Biosciences (PACB) in Q2 2017, closing a stake of 19,500 shares — an estimated $137K sold.

Biondo Investment Advisors first reported a position in PACB in Q4 2015 and held it in 5 quarters. The position peaked at $256K in Q4 2015. 107 funds tracked by Wall St. Rank hold PACB as of Q2 2017.

Biondo Investment Advisors reported no remaining Pacific Biosciences position as of Q2 2017 after selling out during the quarter.
Biondo Investment Advisors sold 19,500 Pacific Biosciences shares in Q2 2017, an estimated $137K.
Biondo Investment Advisors first reported a position in Pacific Biosciences in Q4 2015 and held it in 5 quarters.
Biondo Investment Advisors's Pacific Biosciences position peaked at $256K in Q4 2015.
107 funds tracked by Wall St. Rank held Pacific Biosciences as of Q2 2017.

Based on Biondo Investment Advisors's 13F filing for Q2 2017, filed 11 Aug 2017.